Specifically, the limited sample size of NPC1L1 eQTL within the GTEx program, coupled with the absence of NPC1L1 eQTL data in blood samples, might have resulted in an underestimation of the efficacy of NPC1L1 inhibitors in managing gout and urate. This evidence concerns the gene NPC1L1 and gout.